An incredible day - RSV vaccine recommended by #ACIP for adults >60 and older should receive a single dose of one of the 2 approved vaccines! It is thrilling to see the potential improvement in quality and quantity of life that these vaccines will provide!

🆕 Episode of #Breakpoints: You may ❤️ it. You may hate it. You may think it’s the equivalent of doing your own taxes (hi, Adi), but this episode is all about SMX/TMP! @emilylheil & Andrew Fratoni join Jillian Hayes to unpack the data in this space 🎧 sidp.pinecast.co

I think we are almost there to use this tool at the bedside!!! We are working with a group of experts in SOT and HCT to come up with some recs Camille Nelson Kotton

✅ RCT data shows no difference in AKI btwn TZP+ VAN vs FEP+VAN ✅ “authors provide a roadmap for such embedded randomised clinical trials” the coolest thing about ACORN is the fact that they did it. learning while doing!! Steven Tong JAMA jamanetwork.com/journals/jama/…

Going to #ASHP Midyear 2023 - Come meet with us to hear about our open Clinical Oncology Pharmacist Positions (INP & OP Hematology, SCT, and OP Oncology) UMiami Health System Sylvester Comprehensive Cancer Center 🙌 careers.ashp.org/jobs/19209951/…

🆕Episode of #Breakpoints: Dr. Ajit Limaye & Dr. Camille Kotton (Camille Nelson Kotton) join Dr. Erin McCreary (Erin McCreary) to discuss fascinating updates in the CMV space including new RCTs for prevention, vaccines, & more! Learn why a little "hair of the dog" might be a good thing.

🆕️🔥Cohort study In this 5-year, 68-hospital cohort study of 11 590 hospitalized patients with asymptomatic bacteriuria, only 1.4% developed bacteremia from a presumed urinary source, while 72.2% received empiric antibiotic therapy for UTI #IDXposts jamanetwork.com/journals/jaman…

‼️New in JAMA Network Open w Michigan HMS: Risk of bacteremia in hospitalized adults with #ASB Key findings: In patients with #ASB, bacteremia from a presumed urinary source was rare: ~1.4% overall <1% in #AMS <1% in #AMS + #dementia ~3% if signs of sepsis 📰:jamanetwork.com/journals/jaman…

🚨 Join our #IDteam Yale New Haven Health ! We have an additional opening for a multi-specialty #IDpharmacist for Yale New Haven Hosp 🦠🔬 Message me for more info or apply here 👇: jobs.ynhhs.org/jobs/65909?lan… Matthew Davis Abriana Holzworth, PharmD, BCIDP Emily Weisz Yale ID Fellows SIDP ACCP INFD PRN

Happy Friday! A new episode is now available. Bug Pharmacist 💊🧫 Tim Gauthier joins the podcast to talk about antimicrobial stewardship, antibiograms and more. I also ask him if he has a favorite organism. Download it today! Link in comments. #microbiology #medlabsci #podcast #IDtwitter #Friday

In this study, we estimate the incidence of HHV-6 reactivation and encephalitis after CAR T. Erika Kampouri Jordan Gauthier HHV-6 Reactivation and Disease Are Infrequent in Chimeric Antigen Receptor T-cell Therapy Recipients bit.ly/3y1Cs7u

BTK is known for its role in BCR signaling & BTKi transformed the therapy of lymphoid malignancies. But why do BTKi cause fungal disease? We show that BTK drives neutrophil antifungal activity via p40phox and RAC2 activation; GMCSF rescues BTKi PMN defects jci.org/articles/view/…

🆕 Antifungal TDM toolkit Download the infographics here: funguseducationhub.org/fungal-tdm/

📰 Extra! Extra! Read all about the 2024 updates to the IDSA Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Below are highlights from the Notable Updates from 2023 section. For more info: buff.ly/3WdrVyr #AntimicrobialResistance #IDTwitter

Excited to have the newest version published - appreciate the teamwork with many including ⁦Raymund Razonable⁩ ⁦Dr Roy Chemaly ⁦Yoichiro Natori⁩ - Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients academic.oup.com/cid/advance-ar…

Please join ESGICH for our first session of our Webinar Series on September 24 at 12pm CET/8pm Melbourne/6am EST. This webinar will focus on Stewardship in ICHs. Chairs: Abby Douglas & Mark DeBoer Talks by: Jason Trubiano 🆔, Alessandra Mularoni & Dr. Milkulska escmid-org.zoom.us/webinar/regist…

Management of resistant and refractory cytomegalovirus infections after transplantation: Expert Review of Anti-infective Therapy tandfonline.com/doi/full/10.10…

Would everyone benefit from extended letermovir prophylaxis after day100? Here we discuss risk factors for delayed csCMVi in a retrospective study at Mayo Clinic Infectious Diseases Raymund Razonable Mayo Clinic Hematology-Oncology Fellowship onlinelibrary.wiley.com/doi/10.1111/ti…

Nice effort to make a useful infographic to help patients Might have been a good idea to you know, include a pharmacist who does this multiple times per day for their input as well.... oh wait this is the AMA's journal, how do they feel about pharmacists again?

🚨 🚨 We are recruiting for a PGY2 Pharmacy Resident in Infectious Diseases Yale New Haven Hosp in New Haven, CT. Learn more by joining one of our open houses. Register: surveymonkey.com/r/VWBZQKD or QR below and zoom link will be emailed prior to the session.